Clinical Trials Browser

Phase 2 × Lung Neoplasms × satraplatin × Clear all

NCT00370383 2012-08-07

A Study Comparing Sequential Satraplatin & Erlotinib to Erlotinib in Unresectable Stage 3/4 Non-small-cell Lung Cancer (NSCLC)

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms